Nile

German COVID-19 deaths reach highest level in 9 months

COVID-19 deaths in Germany reached its highest level in nine months on Wednesday with 446 deaths. Germany’s infectious disease agency said the country saw 67,186 new cases along with the 446 new deaths from the virus, Reuters reported.&…

Serum Institute seeks DCGI’s approval for Covishield as booster dose

In an application to the Drugs Controller General of India (DCGI), Prakash Kumar Singh, the Director, Government and Regulatory Affairs at Serum Institute of India (SII) cited that the UK’s Medicines and Healthcare products Regulatory Agency has already approved the booster dose of AstraZeneca ChAdOx1 nCoV-19 vaccine, they said.

Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19

Rockville, Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system.  The ACTT-3 trial assessed the efficacy and safety of interferon beta-1a plus remdesivir compared to remdesivir alone in hospitalized adults with COVID-19. Preliminary data from prior small …

Emmes Announces Completion of Third ACTT Clinical Trial for COVID-19 Read More »

The diabetes medication that could revolutionize heart failure treatment

A medication originally used for patients with diabetes is the first to help people with heart failure and could revolutionize treatment. Early research had shown that SGLT2 inhibitors could help around half of heart failure patients — those with a condition known as reduction ejection fraction. But a new study shows that the medication could …

The diabetes medication that could revolutionize heart failure treatment Read More »

Medinfar awarded first ever CPhI Verified Certificate

CPhI awards the first ever CPhI Verified certificate to Medinfar – an international pharmaceutical manufacturer of Rx, cosmetics, food supplements and veterinary products. The new certification was given after a detailed evaluation by SGS – the world’s leading verification, inspection and certification company – spanning some 14 separate criteria, including the company’s approach to quality and environmental management, supply …

Medinfar awarded first ever CPhI Verified Certificate Read More »

Nigeria detects omicron in case from October

Nigeria has detected its first case of the new omicron coronavirus variant in a case from October, a month before the strain was announced in South Africa.Nigeria Center for Disease Control said a positive test by an international traveler in…

Obama visits vaccination site in DC

Former President Obama, accompanied by the country’s top infectious disease expert Anthony Fauci, surprised a vaccination clinic in Washington, D.C., on Tuesday, visiting the center and encouraging people to get vaccinated, reports The…

15 traits of effective bosses and how to catalyse your team

Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. This post looks at people manager effectiveness and how to boost team and co-worker engagement. It’s that special time in the annual corporate lifecycle: …

15 traits of effective bosses and how to catalyse your team Read More »

New private equity investment makes Iodine Software the latest healthcare unicorn

Advent International, a private equity firm, is investing an undisclosed amount into Iodine boosting its valuation beyond $1 billion. The hope is that the company’s AI-powered clinical documentation improvement software can capture a greater share of the market for software products that help hospitals code and bill accurately to receive reimbursement.

Curie Therapeutics unveils $75M to widen scope of radiopharmaceuticals for cancer

Radiopharmaceuticals deploy radiation to damage cancer DNA, but Curie Therapeutics sees these therapies opening the door to a wider range of ways to kill tumors. The startup has raised $75 million in Series A financing to advance its research.

Sanofi snaps up acne vaccine developer Origimm Bio

Sanofi has added to its vaccine pipeline with an agreement to acquire Austria’s Origimm Biotechnology and its vaccine-based immunotherapy for people with acne. The French group said that ORI-001, a vaccine based on recombinant proteins from the  Cutibacterium acnes (formerly Propionibacterium acnes) bacterium that is often found in acne lesions, could be the first ever …

Sanofi snaps up acne vaccine developer Origimm Bio Read More »

For Older Adults, Smelling the Roses May Be More Difficult

The reports from covid-19 patients are disconcerting. Only a few hours before, they were enjoying a cup of pungent coffee or the fragrance of flowers in a garden. Then, as if a switch had been flipped, those smells disappeared. Young and old alike are affected — more than 80% to 90% of those diagnosed with …

For Older Adults, Smelling the Roses May Be More Difficult Read More »

Watch: No Extra Resources for Children Orphaned by Covid

The number of U.S. deaths from covid-19 has surpassed 778,000. Left behind are tens of thousands of children — some orphaned — after their parents or a grandparent who cared for them died. In this report, co-produced with PBS NewsHour, KHN correspondent Sarah Varney looks at the risks these grieving children face to their well-being, …

Watch: No Extra Resources for Children Orphaned by Covid Read More »

Merck’s oral COVID drug squeaks past FDA advisory committee

An FDA advisory committee voted by 13 to 10 to recommend emergency-use authorisation for Merck & Co and Ridgeback’s oral antiviral molnupiravir for mild-to-moderate COVID-19, saying it would be useful for some high-risk patients. The panel met shortly after updated results from the phase 3 MOVE-OUT trial of the drug showed it was less effective …

Merck’s oral COVID drug squeaks past FDA advisory committee Read More »

Health Data Privacy Protection Requires Cultural Changes and A Holistic Approach

Marti Arvin, VP of Privacy & Compliance, CynergisTek While practitioners tend to think about electronic health records (EHRs) as a modern convenience or necessity following centuries of hand-written and typed charts, the switch from pens and typewriters to computers also transformed scattered medical notes into data – personal information that forms a collectively valuable and …

Health Data Privacy Protection Requires Cultural Changes and A Holistic Approach Read More »

Serum Institute delivers first Novavax shot through COVAX

The world’s biggest vaccine maker exported 137,500 doses of Covovax, as it calls the shot, to the Southeast Asian country last week. Indonesia has approved the vaccine but India and the World Health Organization, which co-leads the COVAX vaccine-sharing network, have not.

Read the Prime Minister’s statement about Australia’s COVID-19 response and the new Omicron strain.

Federal Judge Halts Health Care Worker Vaccine Mandate Nationwide

The health care worker vaccine mandate is now on ice. A federal judge on Tuesday issued a preliminary injunction to stop the start of the national vaccine mandate for all providers covered by the Medicare and Medicaid Conditions of Participation (CoPs), a group that includes home health agencies. The move comes just one day after …

Federal Judge Halts Health Care Worker Vaccine Mandate Nationwide Read More »

LeBron James enters NBA’s COVID-19 health and safety protocols

Los Angeles Lakers star forward LeBron James is entering the NBA’s COVID-19 health and safety protocols, meaning he will be sidelined for the foreseeable future, according to multiple reports.The Athletic reported that James will miss Tuesday night’…

FDA panel backs first-of-a-kind COVID-19 pill from Merck

A panel of U.S. health advisers narrowly backed the benefits of a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the virus.

In children with multiple sclerosis, teriflunomide tempers lesion growth

A phase 3 clinical trial tested the safety and efficacy of teriflunomide, an oral immunomodulatory drug, in children with multiple sclerosis. Although the medication did not prevent disease relapses to a greater extent than placebo, the option for some patients to switch from placebo to teriflunomide before the end of the trial likely biased the …

In children with multiple sclerosis, teriflunomide tempers lesion growth Read More »

Dallas children’s hospital disbands gender-affirming care program

The closing of a prominent gender-affirming care program for children in Dallas has dismayed parents across Texas who say that options for their children’s care are few and far between — and they don’t know what comes next for kids who need similar care.

Part B Home Health Episodes Increased Dramatically in 2020

The demographic profile of home health users continues to skew older, with the vast majority of individuals also having three or more chronic conditions. The setting users found themselves prior to starting home health services additionally continues to skew toward the broader community. That’s according to the 2021 Home Health Chartbook, released earlier this month …

Part B Home Health Episodes Increased Dramatically in 2020 Read More »

CVS Pharmacy “Talking” Prescription Labels Now Available Nationwide

What You Should Know: – CVS Pharmacy today introduced Spoken Rx, its proprietary audio prescription label solution developed in collaboration with the American Council for the Blind, now available in all of its nearly 10,000 locations nationwide.   CVS Pharmacy, the retail division of CVS Health (NYSE: CVS) is now offering Spoken Rx™, its proprietary audio prescription label solution, in all its nearly 10,000 pharmacy locations …

CVS Pharmacy “Talking” Prescription Labels Now Available Nationwide Read More »

Zoom Announces Cerner EHR Integration for Secure Virtual Visits

What You Should Know: – Zoom is now accepting beta customers for Zoom’s new integration with Cerner’s electronic health record (EHR) platform, available by sending a message of interest on Cerner’s App Gallery or talking to your Zoom account executive. – Hospitals, health systems, physician offices, and clinics that use Cerner to share and access patient EHR data across the continuum of care …

Zoom Announces Cerner EHR Integration for Secure Virtual Visits Read More »

Femtech Startup Babyscripts Secures Additional $7.5M for Virtual Maternity Care Solution

What You Should Know: – Femtech startup Babyscripts, the leading virtual care platform for managing obstetrics, has announced an additional $7.5M has been raised during the second close of their Series B funding round. – Investments from Cigna Ventures, Texas Medical Center Venture Fund and Atlantic Health System brings the Series B raise to $19M to date. Babyscripts has raised …

Femtech Startup Babyscripts Secures Additional $7.5M for Virtual Maternity Care Solution Read More »

Labcorp Offers Observed Collections of COVID-19 PCR testing in Over 500 Patient Service Centers

What You Should Know: Labcorp announced that it is offering an observed collection of COVID-19 PCR testing in over 500 patient service centers nationwide. Labcorp (NYSE: LH) is now offering observed self-collection for COVID-19 PCR testing in more than 500 of its patient service centers (PSCs) nationwide for people without symptoms or known exposure. Labcorp plans to offer this service in over 1,000 locations by mid-December – better preparing …

Labcorp Offers Observed Collections of COVID-19 PCR testing in Over 500 Patient Service Centers Read More »

FDA advisers narrowly endorse Merck’s COVID-19 antiviral pill

An advisory group for the Food and Drug Administration (FDA) has voted to recommend Merck’s COVID-19 antiviral pill for infected adults at high risk for severe coronavirus illness, hospitalization or death.The panel narrowly endorsed Merck’s five-…

Supreme Court hears case on 340B payments

Provider groups asked the court to reverse a nearly 30% cut in 340B reimbursements CMS initiated in 2018, since the agency didn’t research hospitals’ average drug acquisition costs.

Milestone as EMA starts review of Atara’s ‘off-the-shelf’ cell therapy

Atara Biotherapeutics’ tabelecleucel (tab-cel) has become the first ‘allogeneic’ cell therapy – in other words one which doesn’t involve harvesting cells from patients – to be evaluated by a regulatory agency anywhere in the world. The EMA has started a review of the off-the-shelf therapy as a treatment for patients with a rare form of …

Milestone as EMA starts review of Atara’s ‘off-the-shelf’ cell therapy Read More »

South African Company Nears License to Sell J. & J. Covid Shot Across Africa

The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.

South African Company Nears License to Sell J. & J. Covid Shot Across Africa

The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.

South African Company Nears License to Sell J. & J. Covid Shot Across Africa

The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.

South African Company Nears License to Sell J. & J. Covid Shot Across Africa

The new agreement makes Aspen Pharmacare the first African company to market a Covid vaccine on the continent. But it stops short of allowing Aspen to make the ingredients in the vaccine.

Providers, Policymakers Lean on Training-and-Apprenticeship Programs to Beef Up Home-Based Care Workforce

As workforce challenges continue to plague the home-based care industry, providers and policymakers are leaning on training and apprenticeship programs to help close the gap. In September, City College of San Francisco (CCSF), UC San Francisco (UCSF) and Homebridge, a San Francisco-based in-home care organization, teamed up on such an initiative. Together, the three organizations …

Providers, Policymakers Lean on Training-and-Apprenticeship Programs to Beef Up Home-Based Care Workforce Read More »

Medicare Advantage Is Becoming a Bigger Home Health Payer, But Fundamental Challenges Remain

With Medicare Advantage (MA) enrollment on the rise, home health providers need to be primed to adapt to the changing market. MA has played a larger role in the Medicare program over the last several years. MA enrollees have increased by 8.3%, on average, over the last five years, according to data from post-acute analytics …

Medicare Advantage Is Becoming a Bigger Home Health Payer, But Fundamental Challenges Remain Read More »

Synthetic tissue can repair hearts, muscles, and vocal cords

Combining knowledge of chemistry, physics, biology, and engineering, scientists from McGill University develop a biomaterial tough enough to repair the heart, muscles, and vocal cords, representing a major advance in regenerative medicine.

WTF Health: Accolade Navigates Itself into New Territory: CEO on Personalized Healthcare & Tech Infrastructure

By JESSICA DaMASSA, WTF HEALTH Healthcare navigator Accolade (NASDAQ:ACCD) is on the move. Not only are they now cruising in care delivery territory with two new primary care/mental healthcare offerings that let them personally guide their 9M members further into the healthcare system, BUT they’re also starting to talk more and more about their tech …

WTF Health: Accolade Navigates Itself into New Territory: CEO on Personalized Healthcare & Tech Infrastructure Read More »

Con el fin de las licencias pagas por covid, empleados sienten la presión de ir a la oficina

Tanto economistas como expertos en salud pública dicen que la licencia por enfermedad con goce de sueldo es una herramienta esencial, tanto como las pruebas, las máscaras y las vacunas, en el esfuerzo por prevenir la infección por covid-19 y mantener seguros los lugares de trabajo. Sin embargo, Estados Unidos se encuentra en medio de …

Con el fin de las licencias pagas por covid, empleados sienten la presión de ir a la oficina Read More »

Eisai forges alliance with FCNT on digital tools for dementia

Japanese drugmaker Eisai has teamed up with Fujitsu spin-out FCNT, which makes smartphones aimed at older consumers, on digital tools to support people with dementia. Eisai has licensed rights to a cognition-checking algorithm developed by Australian digital health company Cogstate, which it uses in an app – called NouKNOW – that allows people to check …

Eisai forges alliance with FCNT on digital tools for dementia Read More »

After Phase 3 failure busts blockbuster bid, Deciphera restructures; staff slashed 35%

Deciphera Pharmaceuticals’ corporate restructuring will slash headcount by 35% and stop work on two drug programs. Going forward, the biotech said it will focus on developing drugs that have the potential to be the first or the best in their therapeutic classes.

Omicron and Other Coronavirus Variants: What You Need to Know

Americans, already weary of a pandemic nearly two years long, were dealt a new blow during the long Thanksgiving weekend: the announcement that a new coronavirus variant had emerged. The omicron variant, officially known as B.1.1.529, surfaced in November in several southern African nations. It set off alarm bells worldwide when public health officials in …

Omicron and Other Coronavirus Variants: What You Need to Know Read More »

SLIC prepares for new campaign on preventing work-related MSDs

Image by Luis Quintero, from Pexels Back to news 03/12/2021 SLIC prepares for new campaign on preventing work-related MSDs In the context of the ongoing Healthy Workplaces Campaign `Lighten the Load’ , an inspection campaign aiming to prevent work-related musculoskeletal disorders (MSDs) is ready to launch. Recently, a preparatory meeting took place between the Senior…See …

SLIC prepares for new campaign on preventing work-related MSDs Read More »

Health in 2 Point 00, Episode 242|Owlet, EasyHealth, Luma Health, Calal Health, and more

Today on Health in 2 Point 00, Jess and I talk about the FDA informing Owlet, whose CEO Jess interviewed about their products and business model, that they can no longer sell their socks. EasyHealth, a medicare advantage broker, gets 35 million plus 100 million credit. Luma Health gets 130 million, bringing their total up …

Health in 2 Point 00, Episode 242|Owlet, EasyHealth, Luma Health, Calal Health, and more Read More »

First NYC safe havens for drug use cleared to open, de Blasio says

New York City Mayor Bill de Blasio (D) announced Tuesday that the first supervised drug consumption facilities in the city have been cleared to open.The Overdose Prevention Center (OPC) services were announced in coordination with the city’s…

Biden global COVID-19 response coordinator steps down

The head of the Biden administration’s global COVID-19 pandemic response is stepping down from her role after eight months, Secretary of State Antony Blinken announced Tuesday.Gayle Smith will return to her position as leader of the ONE Campaign, an…

Unvaccinated Greeks aged 60 and older to face fines

Greek adults ages 60 and older will face fines if they do not get vaccinated, according to a new initiative unveiled by the prime minister that is meant to increase inoculations among older individuals.Prime Minister Kyriakos Mitsotakis…

GSK poaches Pfizer exec Dormitzer as new vaccines R&D chief

GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from Pfizer. Phil Dormitzer Dormitzer is due to take up his new role at GSK on Friday, and will report to chief scientific officer and group president of R&D …

GSK poaches Pfizer exec Dormitzer as new vaccines R&D chief Read More »

Covishield’s effectiveness in fully vaccinated individuals 63% during 2nd wave: Study

“More importantly, the scientists also observed that the spike-specific T-cell responses were conserved against both the delta variant and wild-type SARS-CoV-2. Such cellular immune protection might compensate for waning humoral immunity against the virus variants and prevent moderate-to-severe disease and need for hospitalisation,” the study said.

Pharma’s new leaders in field engagement: MSLs

As the COVID-19 pandemic hit and healthcare professionals (HCPs) became elusive, Medical Science Liaisons (MSLs) got to work by deftly transitioning into virtual engagement. With this transition came an expansion in responsibilities that has resulted in MSLs occupying a central role in pharma’s field engagement strategy.   But, what now? Some industry insiders didn’t expect …

Pharma’s new leaders in field engagement: MSLs Read More »

Where’s Our National Health Tech Academy

By KIM BELLARD It has been said that if your company has a Chief Innovation Officer or an Innovation Department, it’s probably not a very innovative company. To be successful, innovation has to be part of a company’s culture, embraced widely, and practiced constantly.   Similarly, if your company has a Chief Digital Officer, chances …

Where’s Our National Health Tech Academy Read More »

Does Laptop Wi-Fi Affect Fertility?

Should laptops not be on laps? What is the effect of WiFi exposure on sperm motility and DNA damage? “It is impossible to imagine a modern socially-active man who does not use mobile devices and/or computers with Wi-Fi function.” Might cell phones or wireless internet be harmful for male fertility? You may recall that I’ve …

Does Laptop Wi-Fi Affect Fertility? Read More »

Omicron brings COVID-19 vaccine inequity ‘home to roost’

The hoarding of limited COVID-19 shots by rich countries — creating virtual vaccine deserts in many poorer ones — doesn’t just mean risk for the parts of the world seeing shortages; it threatens the entire globe.

CDC says ages 18 and up should get booster shot

The Centers for Disease Control and Prevention on Monday broadened its recommendation for COVID-19 booster shots for all adults as the new omicron variant is identified in more countries.

With Federal Covid Sick Leave Gone, Workers Feel Pressure to Show Up at Work

Economists and public health experts alike say paid sick leave is an essential tool — like testing, masks and vaccines — in the effort to prevent covid-19 infection and keep workplaces safe. Yet the U.S. is in the midst of another covid holiday season, and federal laws that offered covid-related paid sick leave to workers …

With Federal Covid Sick Leave Gone, Workers Feel Pressure to Show Up at Work Read More »

Sun Pharma arm settles case with Biofrontera, to get USD 22.5 mn

In 2018, DUSA Pharmaceuticals had filed a suit at the US District Court of Massachusetts against Biofrontera Inc Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG (together known as Biofrontera) alleging “misappropriation of trade secrets, tortious interference of contract and unfair trade practices”.

Scotland expands vaccine rollout in the face of rising Omicron cases

The Scottish government aims to expand and advance their COVID-19 booster programme, following the six cases of the Omicron variant that were reported as of Monday 29 November. This decision is based on advice from the Joint Committee on Vaccination and Immunisation (JCVI).

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022)

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) is held on June, 20-21, 2022 in Berlin, Germany. The Congress gathers pharmaceutical companies, CMOs and CDMOs, governmental bodies together with pharmaceutical equipment providers and service companies to discuss the manufacturing and packaging processes of the pharmaceutical industry. Among the participating companies are Bayer, Sandoz, Merck, Novartis, Roche, …

Pharmaceutical Manufacturing & Packaging Congress (PHARMAP 2022) Read More »

GSK aim for HIV cure by 2030

Following its recent approval of an injectable HIV-1 treatment from the National institute for Health and Care Excellence (NICE), GlaxoSmithKline (GSK) has high hopes in developing a cure for the virus in the future.

Find out what we know about Omicron, its severity and transmissibility, and how we are working to protect Australians.

Making medicines sustainable

Healthcare’s sustainability record to date leaves much to be desired. The sector contributes 4.4% of total global emissions, healthcare costs continue to rise, and waste is rife. At the same time, two billion people lack access to even basic healthcare.   These are big problems but there is one way to act on them at …

Making medicines sustainable Read More »

Health Innovators: Senseonics’ Francine Kaufman

In the most recent of the Health Innovators video series, pharmaphorum’s founder, Dr Paul Tunnah, chats with the chief medical officer of Senseonics. Francine Kaufman discusses how Senseonics is helping patients monitor their diabetes with the first fully implantable long-term continuous glucose monitoring (CGM) system. Monitoring glucose values is necessary for diabetes patients, and technologically …

Health Innovators: Senseonics’ Francine Kaufman Read More »

FDA sets Sept review date for BMS’ psoriasis drug deucravacitinib

The FDA has kicked off its review of Bristol-Myers Squibb’s psoriasis therapy deucravacitinib, setting an action date of 1 September next year, as the EU and Japanese regulators also start their appraisals of the drug. If approved, deucravacitinib would become the first tyrosine kinase 2 (TYK2) inhibitor approved for the treatment of any disease, said …

FDA sets Sept review date for BMS’ psoriasis drug deucravacitinib Read More »

Moderna boss predicts current vaccines may be less effective against Omicron covid

Stock markets dip as CEO says firms may struggle in targeting both new strain and existing Covid variants The chief executive of the US drugmaker Moderna has predicted that existing vaccines will be less effective against Omicron than they have been against the Delta version, sending global stock markets sharply lower. Stéphane Bancel said while …

Moderna boss predicts current vaccines may be less effective against Omicron covid Read More »

Ms. Olabunbi Underwent Unilateral Hip Replacement in Indraprastha Apollo Hospital, India

Introduction A young 23-year-old woman, Aderiyike Olabunbi, traveled from Nigeria with her mother to get treated for her fractured hip. After suffering from an accident she fractured her hip. That is when she got in touch with professionals at MediGence who guided her and her mother through the entire process. Her consultations were arranged through …

Ms. Olabunbi Underwent Unilateral Hip Replacement in Indraprastha Apollo Hospital, India Read More »

‘I Can Go Anywhere’: How Service Dogs Help Veterans With PTSD

It was supper time in the Whittier, California, home of Air Force veteran Danyelle Clark-Gutierrez, and eagerly awaiting a bowl of kibble and canned dog food was Lisa, a 3-year-old yellow Labrador retriever. Her nails clicking on the kitchen floor as she danced about, Lisa looked more like an exuberant puppy than the highly trained …

‘I Can Go Anywhere’: How Service Dogs Help Veterans With PTSD Read More »

EU-OSHA´s Interim Executive Director at the Employment Committee of the European Parliament

30/11/2021 EU-OSHA´s Interim Executive Director at the Employment Committee of the European Parliament Image EU-OSHA´s Interim Executive Director, William Cockburn, presents the Agency´s contribution to the new Strategic Framework on Health and Safety at Work 2021-2027 at the Employment Committee of the European Parliament. He is also giving an update on our current Healthy Workplaces Lighten the …

EU-OSHA´s Interim Executive Director at the Employment Committee of the European Parliament Read More »

Blueprint inks deal to buy lung cancer biotech Lengo

Targeted cancer drug specialist Blueprint Medicines has agreed to pay $250 million upfront to acquire Lengo Therapeutics and its lead drug for lung cancer, a rival to already-approved therapies from Johnson & Johnson and Takeda. There’s another $215 million tied to the achievement of regulatory and sales-based milestones with LNG-451, a compound that targets tumours …

Blueprint inks deal to buy lung cancer biotech Lengo Read More »

AZ eyes FDA verdict on Lynparza in adjuvant breast cancer in Q1

The FDA will deliver a verdict on AstraZeneca’s PARP inhibitor Lynparza as an adjuvant treatment for breast cancer in the first quarter of next year, after granting the application a priority review. AZ and partner Merck & Co have filed Lynparza (olaparib) for use in BRCA-mutated, HER2-negative early breast cancer in patients who have already …

AZ eyes FDA verdict on Lynparza in adjuvant breast cancer in Q1 Read More »

Dr Lucas De Toca, COVID-19 Primary Care Response First Assistant Secretary, answers the top 3 questions across our channels.

Rethinking Patient Access: 4 Key Action for Health Systems

Erin Jospe, MD, Chief Medical Officer at Kyruus As we learn to equilibrate with COVID-19, we are collectively learning how to modulate our acceptance of risk in order to re-emerge and engage with the world around us. It has at times over the course of the pandemic been a necessary choice, oftentimes in the name …

Rethinking Patient Access: 4 Key Action for Health Systems Read More »

How often do health plans use “provider requirements”?

Specialty drugs have delivered significant improvements to patient health, but oftentimes they pay be expensive. To try to insure that these treatments are used appropriately, some health plans impose a utilization management tool known as “prescriber requirements” where only certain types of physicians may prescribe a drug. While this may be useful for some complex …

How often do health plans use “provider requirements”? Read More »

Children’s COVID-19 Vaccine: A Key to Protecting Pediatric Asthma Patients

What Has Everyone Excited about COVID-19 Vaccines for 5-11-year-olds? With the rollout this month of the COVID-19 vaccine for those 5-11 years of age, we can now directly protect children with asthma for whom COVID-19 infection is an even bigger hazard for our children during the pandemic. During the COVID-19 pandemic, the term “comorbidities” has …

Children’s COVID-19 Vaccine: A Key to Protecting Pediatric Asthma Patients Read More »

Read the Prime Minister’s statement about temporarily pausing the planned easing of border restrictions.

Matthew’s health care tidbits: Drug prices

Each week I’ve been adding a brief tidbits section to the THCB Reader, our weekly newsletter that summarizes the best of THCB that week (Sign up here!). Then I had the brainwave to add them to the blog. They’re short and usually not too sweet! –Matthew Holt For my health care tidbits this week, I …

Matthew’s health care tidbits: Drug prices Read More »

GAO on the Cost of Rare Diseases

Last month, the Government Accountability Office released a report on the cost of rare disease. The report is interesting, and especially interesting is Appendix 1 which has a detailed list of studies of the cost of rare disease for about 50 rare diseases. Below are some highlights: Currently, there are no treatments or cures for …

GAO on the Cost of Rare Diseases Read More »

Biden reignites debate over travel bans

The Biden administration is facing heavy criticism for its decision to impose a travel ban on South Africa and several nearby countries in the wake of the omicron variant, reigniting a debate from some of the earliest days of the pandemic. The…

CMS Vaccine Mandate Blocked in 10 States

First it was the COVID-19 vaccination mandate from the U.S. Occupational Safety and Health Administration (OSHA). Now, it’s the one from the Centers for Medicare & Medicaid Services (CMS). Since OSHA and CMS released their interim emergency regulations requiring COVID-19 vaccinations for certain individuals, each has been challenged in court. On Monday, a federal judge …

CMS Vaccine Mandate Blocked in 10 States Read More »

Dallas Cowboys head coach tests positive for COVID-19

Dallas Cowboys head coach Mike McCarthy will miss his team’s upcoming game against the New Orleans Saints after testing positive for COVID-19, The Associated Press reported. McCarthy, who’s in his second season as Dallas’s head signal-caller,…

US braces for omicron to hit

The United States is bracing for the impact of the omicron variant of coronavirus, which has yet to be detected in the nation but is seen as an inevitability.Much is still unknown about the new variant, and experts say it could be about two weeks…

The Australian Public Service employee census report for 2021 has been released. Read more about the census and Health’s results.

Cell therapy biotech Quell adds $156M for alternative to organ transplant meds

Quell Therapeutics’ $156 million Series B round comes as it prepares to advance to a clinical trial testing its lead regulatory T cell therapy candidate as way to prevent organ rejection in liver transplant patients. The progress comes as the field of Treg cell therapy research becomes increasingly competitive.

‘Be Vigilant’: What In-Home Care Providers Should Know About the Omicron Variant

The World Health Organization (WHO) on Friday officially designated the COVID-19 variant Omicron as “a variant of concern.” The U.N. agency on Monday followed that up by warning the global risk from Omicron is “very high” based on early evidence, noting the variant could have “severe consequences” as far as future surges. While there’s still …

‘Be Vigilant’: What In-Home Care Providers Should Know About the Omicron Variant Read More »

Transactions: Riverside Invests in Executive Care; Charter Buys Silver Linings Hospice Care

Home care provider Executive Care recently received an investment from global investment firm The Riverside Company. The financial terms were not disclosed. Hackensack, New Jersey-based Executive Care is a private-pay personal care company that operates a network of 13 franchise locations and offers a plethora of services, including companionship, homemaking, personal care and live-in care. …

Transactions: Riverside Invests in Executive Care; Charter Buys Silver Linings Hospice Care Read More »

UK accelerates COVID booster plans in response to Omicron

The UK looks set to extend its COVID-19 booster vaccination programme to all over-18s, as the number of cases of the new Omicron variant of SARS-CoV-2 has reached double figures. The gap between second doses and boosters is also being reduced from six to three months in an attempt to get as much protection in …

UK accelerates COVID booster plans in response to Omicron Read More »